…ell, look, we can just see you'd have to go to around 2009 2010. Now, the dividend gives me another way to set the price. It's $212 a year at $80. That same payment would yield around 2.65%. Coke wouldn't need to sell a single extra drink. So CocaCola for me, it's another one that doesn't break out and stays as a strong sell. Compare it with Proctor and Gamble and hold. I'd happily collect dividends from either business. A Coke buyer is giving up considerably more starting income compared with what buyers have usually received. Now Starbucks is trading around $…
So CocaCola for me, it's another one that doesn't break out and stays as a strong sell.
Contexto extraído por IA
So CocaCola for me, it's another one that doesn't break out and stays as a strong sell. Compare it with Proctor and Gamble and hold. I'd happily collect dividends from either business. A Coke buyer is giving up considerably more starting income compared with what buyers have usually received.
…mber today. Assuming it delivers every single scent. Now, the yield, it is close to normal. You're collecting 2.3% while you wait compared with a 5year average of 2.46. It gives me a little more patience here than what I had with CocaCola. So Starbucks for me, while it breaks out, not that much further, it goes into the sale, the recovery is credible enough to keep it out of my bottom tier, I'd be far more interested closer to the $95 cash flow value where a good surprise might actually benefit the buyer. Now, if you came here for the dividend, this is probabl…
So Starbucks for me, while it breaks out, not that much further, it goes into the sale
Contexto extraído por IA
So Starbucks for me, while it breaks out, not that much further, it goes into the sale, the recovery is credible enough to keep it out of my bottom tier, I'd be far more interested closer to the $95 cash flow value where a good surprise might actually benefit the buyer.
…, the multiple comes in at 220, which is well below today's price. In total, we're still getting a very large premium, 36% where we can also see very trivial upside 3% from Wall Street price target $280, only $8 above today's market value. So Johnson doesn't break out of the strong sell category. The combined value is right around $200 when the price today is in the 270s. Before riding off healthcare as a whole though, let's have a look at the next earnings table. AV is expected to earn nearly $14 this year. Next year $1622, then $…
So Johnson doesn't break out of the strong sell category.
Contexto extraído por IA
So Johnson doesn't break out of the strong sell category. The combined value is right around $200 when the price today is in the 270s. Before riding off healthcare as a whole though, let's have a look at the next earnings table.
…20 at $318. That spread matters. And you can see the more optimistic view here as well. The multiples valuation is $325 and the analyst they see on average $357. I can see a route to those prices. If the standalone cash generation delivers for me FedEx it has to go into the sell at this price with less conviction than Walmart or Coke. I'd move it up for better evidence of cash conversion after the separation. Now Union Pacific it comes in today $300 up strongly 30% year to date. Over the last 5 years though, it's only up 25, tr…
for me FedEx it has to go into the sell at this price
Contexto extraído por IA
If the standalone cash generation delivers for me FedEx it has to go into the sell at this price with less conviction than Walmart or Coke. I'd move it up for better evidence of cash conversion after the separation. Now Union Pacific it comes in today $300 up strongly 30% year to date.
…side. Now, earnings. Whilst the growth is impressive for the company, I need a good reason to expect cash flow to keep outpacing earnings like that for a decade. As we saw with the reverse ETF, that's a bigger bet than this table suggests. UNP it goes into the sell category. We've got one slot left to decide. Remember that industrial stock deep in the red at the start. Here's why I take a closer look at this one. Caterpillars trading $559. The 52- week low, that's $537. 52- week high, sitting above $1,000. Yea…
UNP it goes into the sell category.
Contexto extraído por IA
UNP it goes into the sell category. We've got one slot left to decide. Remember that industrial stock deep in the red at the start. Here's why I take a closer look at this one.
…eet they see upside a little bit more than some the previous but not massive at 9% price target coming in $451. So this 6% is enough to interest me but it's a fairly thin cushion for a model that starts as we said with a fairly large jump. So Visa for me is the first one to enter into the buy tier. Although it's right at the bottom, I would say if the shares run ahead of my estimate tomorrow, I'd happily let them go. The second buy is got a wider gap and a very different risk. We then move to Johnson and Johnson. That's up nearly 32%…
So Visa for me is the first one to enter into the buy tier.
Contexto extraído por IA
So Visa for me is the first one to enter into the buy tier. Although it's right at the bottom, I would say if the shares run ahead of my estimate tomorrow, I'd happily let them go. The second buy is got a wider gap and a very different risk.
…a 47% gain. And the reverse DCF, that's the last check here from that 12 billion starting point. and the market needs around 8% annual growth against the 11 that I've used. I've got some room for error provided the starting point holds up. So, Caterpillar, it takes the top spot in buy ahead of Visa. I can cut Caterpillar's first cash flow estimate by $2 billion and still get close to the price. That's the sort of test that I want a buy to survive. Now, let's look back at Walmart where we started. the best thing that happened to its cu…
So, Caterpillar, it takes the top spot in buy ahead of Visa.
Contexto extraído por IA
So, Caterpillar, it takes the top spot in buy ahead of Visa. I can cut Caterpillar's first cash flow estimate by $2 billion and still get close to the price. That's the sort of test that I want a buy to survive.
…g end. In fact, right now, reverse ETF is coming in at 17.2%. Meanwhile, the regular dividend yield is around half a percent for every $1,000 you put into Costco. That's only around $5 a year coming back to you through the regular payment. So Costco for me it is one that breaks out of the strong sale but only just about into the sale category. I'd rank it above Walmart because investors have regularly paid a multiple in the 40s for Costco. I still want a better entry before betting on that premium lasting another decade. And look how different Proctor and Gamble is. The yield is…
So Costco for me it is one that breaks out of the strong sale but only just about into the sale category.
Contexto extraído por IA
So Costco for me it is one that breaks out of the strong sale but only just about into the sale category. I'd rank it above Walmart because investors have regularly paid a multiple in the 40s for Costco. I still want a better entry before betting on that premium lasting another decade.
Transcrição Completa
Technology fell 19% in 6 weeks. Consumer staples went up nearly 12. So, if you got out of tech and bought the stocks that everybody thinks of as safe, how much did the safety actually cost you? Today's episode, I'm going to be parking 14 dividend stocks along the bottom of this board in the strong cell category. By the end, only two of them are going to enter into the buy. And one of the hardest sales on the list, it's a company that's just raised its guidance. Now look at the consumer staples row prices. Well, they're up 20% this year. Earnings, they're only up around 3% and most of the return, well, it came from investors paying for more of each dollar of profit. That's great if you own them 6 months ago. But what about buying now? A dollar of expected earnings in this sector, it costs around $24. Over the last 5 years, it averaged closer to 21. And that's before we even look at Walmart. And if we look at the heat map, this is the S&P 500 in just the last four weeks. Well, compare Walmart and Caterpillar. One is up around 7%. The other one, well, it's down around 23. Which one would you feel more comfortable owning? Keep your answer in mind. Now, Walmart, it closed at $127 yesterday ahead of its results. But before I rank it, listen to Brian Moneyan at Bank of America. He describes what his customers are actually doing when they go shopping. the spending all come together. So, does it affect people? They make choices. And so, what you see in uh in clothing as we had in the holidays, what we're seeing is movement to places where lower price goods and things like that or you see might see it in terms of restaurant choice um or food buy choice, but in the end of the day, they still spend all the money. It's just they make choices to make sure that they're getting the best value. >> That's a pretty good setup for Walmart. People are still spending and they want value. My question is, how much of that good news a shareholder already pays for it? I mean, just start with the $289 earnings estimate here. The share price, well, it's sitting around $127. And this morning, Walmart lifted its fullear adjusted earnings guidance up to $289. Even at the top end, Wednesday's buyers, they're paying around 44 times those earnings. Now, for context, we can see Walmart's 5year average that sits around 27. The latest reading we've got around 43. So the company it has to earn substantially more for the stock to grow into this kind of a premium. I mean if we look at the blue tunnel from simply safe dividends highlighting intrinsic fair price over the last year there's been a massive disconnect around the share price and the underlining fundamentals. Go back the last 5 years. Last time this was anywhere near a reasonable signal. You'd have to go to 2024. In fact just at the beginning you want to see this company undervalued. Well, very rare to see, just once at the beginning of 2022. And analysts, they do expect growth. They've got $323 after the 289 and then January 2029, we can see $363. Now, 43 analysts, they cover this middle year. I'd happily take doubledigit earnings growth from a retail of this size. But look at the cash flow hurdle. I've allowed 15% a year for 10 years. Follow the cash flow across. We start with their 2026 figure of 15 billion and then we end 10 years later above 60 billion. Even with that much of an improvement, I get to $73 a share. Now the dividend model, it actually likes Walmart here. It gives me $137. I've kept it in the average alongside the multiples valuation of $95. Together, including the DCF, we get to just under $102. So what does the price ask for? close to 22% annual cash flow growth for a decade under these assumptions. Even my higher end of 20% that scenario it only gets to $109. So every single case ranging from 10 to 20% we're talking double digit downside. I mean even using the blended of $102 we get no margin of safety is actually a premium today of 25% where Wall Street well they see upside yes but very trivial 4% the average target over the next year coming in $132 only $5 above today's price so Walmart there's going to be no movement in fact from the strong sale I believe this is where it should be I like the customer story that we just heard from Bank of America but $127. I need an extraordinary amount of that spending to end up as cash in shareholders pockets. And before we leave that rotation, look at Apple. Nvidia is down 31% in just the last month. Apple is green if someone tells you tech has sold off. It's worth asking which tech they mean. Now, Apple is trading around $352, up 30% year to date. Now, we can see the dip in the middle of this chart. That was an opportunity in hindsight. someone buying them at the far right, they're paying a very different price. Let's give that buyer the optimistic case. Analysts, they've got earnings of $942, then $10.57, and then by 2029, just shy of $12. That's roughly a quarter more profit per share in 2 years. If they're right, there's a perfectly good business case for wanting to own this. But what catches my eye is the price. 37 times Ford earnings against a 5year average of 29. the dividend, it gives you about 31 cents a year on every $100 invested at this yield. And whilst that's not the driver for the company, both of these, given that the yield is below the 5-year, the forward P significantly above the average and sitting pretty much at the high in the last 5 years, they in combination point to a potential overvaluation signal. Where the blue tunnel, it only confirms this. But again, like we're seeing from quite a few stocks that we've covered on this channel, Apple is one of those that investors typically pay a premium. Very rare, if at all, to see this in the undervalued level. And if you subscribe anytime we see companies like Apple trading in a severely undervalued level, we will make you aware. Now, just look at free cash flow. It jumped in 2025 from 99 billion up 38% to 136 billion. That's before we've even looked at the 10 years of growth. So I'm giving Apple the benefit of the higher base for the entire forecast. Now using 10% growth moving forwards we get to a value of 272. And Apple as you can see here given the empty boxes we do typically solely focus on a discounted cash flow valuation. So I want to know how easily a better assumption changes the answer. So at 10% growth we can see Apple are expected to produce over 350 billion year by the end of this period. raise the growth to 12%. Well, we can see that comes to $317. That's downside of 10% still below today's market price. Now, our base case of 10% that does equate to no margin of safety and a premium of 29%. Wall Street, while they see a much higher price than what we have, they believe it'll actually be 2% lower over the next 12 months. In terms of reverse ETF, what is the price justified buying at the market value? Well, you need to anticipate at least growth of 13.3%. So, Apple is another one that joins Walmart in the strong sale it doesn't get released from this tier. What would change my mind? A price much closer to $272 or enough evidence to make that high grow case my starting point. Right now, the shareholder carries most of that risk. Now, there's another number worth explaining here. 9%. That's the return I'm asking on those future cash flows. It's why a dollar Apple might generate in 10 years is worth considerably less to me today. And that matters when a whole sector is trading above its usual earnings multiple. Listen to the size of the rate move Fed Governor Chris Wallace said that he wanted policy makers to consider and what prompted him to say it. >> The term aggressive, what does aggressive mean? Well, I gave a speech last week and I said we need to consider a 50 basis point hike if CPI inflation hit three for the month, which I didn't think it was going to, but it did. And that's the third straight month in a row. That average annualized out that's heading for three and a half% not getting closer to two. So, I think that's where we need a more aggressive approach. >> That's one governor's view. My 9% stays fixed across these models. Here's how it works for Costco. Nearly 38 billion of cash flow 10 years out is worth around 16 billion in today's money. Now Costco is trading around $1,100. The fourdigit share price, it doesn't bother me. The stock split, it could change that overnight. What I care about is how much each dollar of the company's earnings costs. And here that figure is nearly 48 times Ford earnings. The 5-year average, it's sitting below that at 43 12. Investors have paid up for this business for years, so it deserves a fair hearing at a premium. And you can see on the blue tunnel, we do get another potential overvaluation signal, although sitting right at the upper end of the blue tunnel stretch out to the last 10 years. Again, very unlikely that you ever see this one in a severely undervalued level. Even going back to the last 20 years, I mean, in terms of a clear undervalued opportunity, you'd have to go back to 2009. So, it just highlights investors constantly believe Costco is worth a premium and they've constantly paid for it. And you can see what they like. Earnings of just under $23, then $25 by 2028 and then $27.51. We're talking around 10% growth 2 years running. If you want predictability, that's a pretty attractive set of estimates. Now, I've been more generous on cash flow. 15% annual growth for a decade. Well, that takes it from 9.4 4 billion to almost 38 billion. Costco could have several genuinely good years and still come up short of that. So, what that does, we can see it brings me to $935. That's 15% below today's price. No margin of safety again, a 17% premium. And we've got Wall Street targets. Well, $1,085. So, they see no upside again. Even with rising earnings, it's hard to find much upside here. And look at how wide the range gets. At 10% growth, I get $647. At 20%, $1,350. If you pay close to $1,100, you're betting that cash generation, it lands closer to the more demanding end. In fact, right now, reverse ETF is coming in at 17.2%. Meanwhile, the regular dividend yield is around half a percent for every $1,000 you put into Costco. That's only around $5 a year coming back to you through the regular payment. So Costco for me it is one that breaks out of the strong sale but only just about into the sale category. I'd rank it above Walmart because investors have regularly paid a multiple in the 40s for Costco. I still want a better entry before betting on that premium lasting another decade. And look how different Proctor and Gamble is. The yield is almost exactly the 5-year average. It earnings multiple is pretty close too. Here's a defensive business where you can make a case for paying today's price. At $170, while Proctor and Gamble, it pays you $4.35 a share. That works out to be around 2 1.5% while you wait. Buying this for income, it feels quite different from buying Costco for the regular dividend. Now, look, you might need a bit of patience. The first earnings estimate we have, it's $6.98, is only around 1% we can see growth. The next two are better $742, climbing up to 782. A steady recovery is already in the forecast. Now, I've allowed 9% cash flow growth, which takes 15.7 billion of free cash flow in 2026 to just over 37 billion over the decade. The reverse DCF, it says the price asks for 8.8%. My view and the markets, they're pretty close. So, the cash flow, it gets us to $173. The combined value here gets to 165 and the shares they're trading around 170. $5 either side of the fair value is far less precision than any of these models can honestly give you. And Wall Street again, they don't really see much upside only 3% over the next 12 months. Price target 175, only $5 above today's market value. So why keep it then? If you already own PNG, the dividend comparison is reassuring. At 2.56%, a new buyer gets roughly the same starting income than the markets typically offered over the last 5 years. And if we look at the blue tunnel, well, it's sitting pretty much bang in the middle. Unlike the last few, there have been many times in just the last 12 months to get this into an undervalued level. Over the last five, bit of a different story. over the last 10. Again, Proctor and Gamble very, very rarely actually enters into an undervalued signal. 2018, it was the last time that we saw this since just the last few months. So, Proctor and Gamble for me today, it goes into the hold. I can see the argument for keeping the shares and collecting that income. I'd want more room in the price before putting fresh money here ahead of my two buys. Of all the consumer names, this price chart surprised me the most. Coca-Cola is up 40% year to date. Fantastic. If you own the move, what does someone paying $98 today get right now? Well, a 2.16% starting yield, the 5year average, much higher at 2.9 on $10,000. That's about $216 a year against $290, the historical yield. Same business, $74 less annual income on the same investment. Now, there is still growth. Earnings go from $335 to 353. And then 2028 we can see $380. The next two growth rates they're around 5 1/2 and 7 1/2% reasonable numbers for a mature company like Coca-Cola. Now management are guiding around 13 billion of free cash flow in 2026. From then we've used 10% growth moving forwards. It gets Coke past 30 billion as we can see by 2035. I would say it's a fairly generous path given the earnings estimates that we've just seen. So this cash flow number we can note here. it gets to $75. Put this alongside the multiples at 87, the DDM at 74, while the average it gets to $79. And even Wall Street target $100 being significantly above our intrinsic value. Only trivial upside of around 2%. So Coca-Cola today, it has a 25% premium. Now, here's what could absorb some of that earnings growth. Coke trades at 28.3 times Ford earnings, 5 years sitting at 23.4. a return towards that level. It could leave shelders going sideways for quite a long time. And you can also see the overvaluation signal that we're noting something actually just recently in the last few weeks over the last five over the last 10. Again, very rare to see this undervalued. You'd have to go end of 2023 and then the COVID drop before that. Well, look, we can just see you'd have to go to around 2009 2010. Now, the dividend gives me another way to set the price. It's $212 a year at $80. That same payment would yield around 2.65%. Coke wouldn't need to sell a single extra drink. So CocaCola for me, it's another one that doesn't break out and stays as a strong sell. Compare it with Proctor and Gamble and hold. I'd happily collect dividends from either business. A Coke buyer is giving up considerably more starting income compared with what buyers have usually received. Now Starbucks is trading around $109. We can see pretty much around 52 week highs at 112. If you're buying the turnaround, you're buying it pretty close to the highs. Luckily, we can put numbers on what that recovery may look like. Now, analysts, they've got $322 in earnings, then $3.73, then $425. Going from the first number to the third is about 32% growth in 2 years. That's a much faster recovery than what we just saw at CO. And investors can see those estimates, too. They're paying around 34 times forward earnings against a 5-year average below 29. Part of the reward for getting the turnaround right is already reflected in the price. So probably no one's surprised to see an overvaluation signal. Maybe the surprise is that we've seen this over the last 12 months. I mean, last time this was severely undervalued. You'd have to go to around the middle of 2024 where it was trading around $70. Now, what gives me pause is the cash flow history along the top. I mean, just compare these ups and downs. We can see quite a lot of them with the smooth climb that I've got in my forecast. 12% growth that we're using here. It gets me to 11.6 billion in the last year. Even then, I get to around $95 on the cash flow model. I mean, that's an overvaluation signal. The reverse ETF is pointing to 13.5% if we to incorporate multiple 79 DDM at 81. Will we get an average value of $85 and $109 today? Well, I need Starbucks to clear a higher bar than just getting back to earnings growth. Wall Street again, no upside, just 2% very trivial at their 52- week high of $111. Another company with a massive premium today. Starbucks sitting at 28%. Now, try this with the third line. Divide $109 by $425 that Starbucks is expected to earn 2 years further out. Well, you're paying, as we can see here, nearly 26 times that future number today. Assuming it delivers every single scent. Now, the yield, it is close to normal. You're collecting 2.3% while you wait compared with a 5year average of 2.46. It gives me a little more patience here than what I had with CocaCola. So Starbucks for me, while it breaks out, not that much further, it goes into the sale, the recovery is credible enough to keep it out of my bottom tier, I'd be far more interested closer to the $95 cash flow value where a good surprise might actually benefit the buyer. Now, if you came here for the dividend, this is probably the one you've been waiting for. Ultra, it pays $444 a share at $76 today. That's about $58 a year on every $1,000 invested. Now look at the black line here. The yield on average has been 7.72% over the last five. That would have paid about $77 on the same thousand. A big yield in absolute terms. It can still be an expensive entry. Now, how quickly can the income grow? Analysts expect $5.70 to $5.92 and there in turn to $616. There's progress, but if the dividend ran well ahead of those numbers for long, more and more of the earnings, well, they would get paid out. Now take the dividend and divide it by the expected earnings. Roughly 78 cents of every dollar is already going to shelters. It helps explain why the starting yield matters so much here. Now it's also a business where you don't need much growth to make the cash flow work. I've used 3% a year. That's pretty much in line with the 5year keer. The price well it implies around 2.3% under the same assumptions. That gets me to $81 here. If we combine all four methods today, well, we get to a price that's pretty much bang on 70. So, there is a real income case, but the valuation changes direction depending on which method you favor today. So, no margin of safety again. We're talking an 8% premium where Wall Street they see downside over the next year of 3% but the price $74 not too dissimilar from today's market value. Now, historically, investors have paid just under 10 times forward earnings for Ultra. Today it's closer to 13 times on the chart. Given the pace of earnings growth, I'd want to be quite careful about paying that premium. And if you want to take a look at the blue tunnel, well, as it has done since the beginning of this year is trading at a premium over the last 10 years, there was a significant portion of time from 2018 to 2022 where it was trading severely undervalued. Now we're seeing the opposite case. While in fact the underlying fundamentals, they are starting to increase. So ultra for me today. It goes into the hold alongside Proctor and Gamble. I understand keeping it for the income. For a new purchase, I'd want more of the usual yield. The first stock I'd actually buy has a dividend yield barely an eighth as high. Now Visa yields 3/4 of 1%. But look at the chart on the right. For a business that regularly changes hands at 26 times earnings, today's 27, it's a fairly familiar entry. And look at what that multiple buys. Analysts expect earnings growth of around 13% then 14% and nearly 14% again by 2029. And we can note there are 38 analyst estimates behind the first number and 32 behind the second. At $415, you're paying about 28 times the first earnings estimate. Remember Coca-Cola? A similar price per dollar of profit, but materially slower expected earnings growth. If I had fresh money for only one, well, I know which one I'd choose. Now, here's what stops me getting too excited. Their latest free cash flow for 2026, that was 22 billion. Now, for 2027, analysts are expecting a jump to 27.2. So, bear that in mind. The analyst projected jump has to happen before my 12% growth assumption kicks in. Now, I'm willing to give Visa some credit if it earns the $19.50 on this line, today's price. Well, it works out as we can see to be around 21 times those earnings. You can see a route for the business to grow into the price. But can it turn enough of that profit into cash? My base case gets me to $443. In the low case at 10% I get to $386. The stock well it sits in between the two quite close in fact to the middle where the reverse ECF at 11% is in line with their 10year keer. So we've gone slightly higher at 12. So there is just a small gap here where we get a margin of safety although fairly small at 6%. Wall Street they see upside a little bit more than some the previous but not massive at 9% price target coming in $451. So this 6% is enough to interest me but it's a fairly thin cushion for a model that starts as we said with a fairly large jump. So Visa for me is the first one to enter into the buy tier. Although it's right at the bottom, I would say if the shares run ahead of my estimate tomorrow, I'd happily let them go. The second buy is got a wider gap and a very different risk. We then move to Johnson and Johnson. That's up nearly 32% year to date. It's the sort of steady climb you'd love the rest of your portfolio to make. Now look at what the rally did to the income opportunity. The yield, well, it's 1.97% against a 5-year average of 2.83. The earnings multiple has gone from a historical 16 to now sitting over 24. Buyers are paying roughly 50% more for a dollar of forward earnings for which we do get a severe overvaluation signal. Massive disconnect from where it sits today and even the upper end of the blue tunnel. I mean over the last 10 years Johnson Johnson other than 2026 I don't think it's really ever been in this severe overvaluation signal. investors are used to paying a reasonable valuation. Now, one line that could make you reconsider the company, earnings are expected to grow, as we can see, around 4% in 2027 and then almost 20% by 2028. The second jump is doing a lot of the work in the growth case. Take today's price $272 and divide it by the $13.90 estimate 2 years out. You're still paying almost 20 times those future earnings. That's asking a buyer to pay for a decent chunk of the improvement pretty much upfront. And my forecast is it starts at $21 billion and it grows cash flow 8% over the longer term. By the latest year, we get 42 billion. So the base case already allows for cash generation to pretty much double. Now what makes this decision easier is the agreement between the boxes. Cash flow says $190. The dividend discount model says $188. And even the highest of the three, the multiple comes in at 220, which is well below today's price. In total, we're still getting a very large premium, 36% where we can also see very trivial upside 3% from Wall Street price target $280, only $8 above today's market value. So Johnson doesn't break out of the strong sell category. The combined value is right around $200 when the price today is in the 270s. Before riding off healthcare as a whole though, let's have a look at the next earnings table. AV is expected to earn nearly $14 this year. Next year $1622, then $18. You don't have to go down several years on the table before growth starts to look interesting. At $286, you're paying around 20 times the first earnings estimate or 18 times the second. For your money, you're getting considerably more expected near-term growth here than you would with Johnson and Johnson. Now, look, don't get me wrong, it's still a premium entry for the company. We can see on the comparison forward multiple 18.2 against a 5year 14 and a dividend that typically yielded over 3%. Well, now it sits at 2.55 for which the blue tunnel also an agreement potential overvaluation sitting above the upper end last 10 years. ABV well pretty much since 2022 this one's been trading at a constant premium. Now analysts are forecasting 19 billion of free cash flow in 2026. Then we've grown at 10%. Now 5year K is negative 10 year KGA that's sit at 12%. Using the growth rate here of 10% we get to 45 billion of free cash flow by 2035. The value comes down today to $247 below the market price. We get an overvaluation signal. reverse DCF at 11.9 pretty much in line with the 10-year keer. And if we look at the other models, well multiples 295, that's above today's price. DDM that also sits above. So the blended number comes at 283. Interestingly though, we can see here the models actually genuinely disagree. So it gets today pretty much sitting around fair value where Wall Street anticipate 10% upside, their average target $316. Now, what would move this into a buy? Probably more confidence in that $18 earnings figure would help. Look across the row, though. We can see the low and the high estimates. There's still what I would say is a pretty meaningful range around what looks like a very precise consensus. For income alone, I can wait. $1,000 invested at this yield. It brings in roughly $25 a year. At the average yield on the same chart, it would have been nearly 36. And today, it goes into the hold bucket. If I were choosing between the two healthcare stocks at these prices, I'd take AVY. The earlier earnings growth, it gives me a better reason to sit through an ordinary year. Fair value $242. Share price $241. Waste management looks like the easiest call on the board. If you stop at the purple box here, the individual values inside that average, it tells a much more interesting story. First, the argument for buying here. The yield 1.6% 6% pretty much in line with the average the forward multiple 28 against the 5year of 27.4. So historically today's entry it looks perfectly ordinary on both measures where we also get a reasonable signal when we look at the blue tunnel. I mean over the last 10 years put this alongside the majority of companies we've discussed today. Very very rarely is this one ever severely undervalued. Now, earnings, they're expected to go from $810 to $8.94 to then just shy of $10 by 2028. Roughly 10% growth we can see in each of the next two years where we've also got 28 analysts who are covering the first two and 21 still covering the third. But look at my cash flow assumption. The latest historical figure coming in just shy of 3 billion. The first forecast which analysts are projecting 3.8 billion. That's a 29% jump before I apply another 10% moving forwards. Even after allowing all of that, the cash flow, it only gets me to $196. When we take a look, the multiples valuation, $260, DDM, $270. It pulls the average back up. That's where the apparently perfect match to the share price came from. And I'd also pay particular attention to the high case of 12%. Even that comes to 233 where there's downside of 3%. So if cash flow is your preferred way to value this business, you need quite a bit to go right from here. Where Wall Street they do see upside but only 7% price target 257. So Waste Management it goes into the hold category alongside Proctor and Gamble. Holders have a reasonable growth case and a familiar valuation for a new purchase. I'd want some of that doubledigit cash flow growth to be a bonus. Now see that step down in June. FedEx freight spun off. Shareholder received one freight share for every two FedEx shares they held. Looking at the parents price on its own, it misses what those shareholders received. It also matters here. Forward multiple 16 against a 5year 13. Much of the history includes the freight business. It's a useful reference, but the business being valued here has changed for the parent. You can buy now start here at $318. The first earnings estimate sits at $1830. It puts you at a forward valuation of around 17 times earnings. The $21 on the next line here, it brings it down to around 15. And if we look at the most recent free cash flow reported, $3.1 billion. Well, this was the company that still included the freight. So, I would give this DCF today a little bit less weight from the standalone business itself. On the original assumptions, cash flow came to 259. The four methoded average came to 272. I treat these as reference points. The separation changed the asset base that has to produce those earnings. So where's the upside case at $2366 estimate for 2028. The shares they would cost 13 12 times earnings. But look at the low estimate that's sitting here below $20 at $318. That spread matters. And you can see the more optimistic view here as well. The multiples valuation is $325 and the analyst they see on average $357. I can see a route to those prices. If the standalone cash generation delivers for me FedEx it has to go into the sell at this price with less conviction than Walmart or Coke. I'd move it up for better evidence of cash conversion after the separation. Now Union Pacific it comes in today $300 up strongly 30% year to date. Over the last 5 years though, it's only up 25, trading towards the upper end of the 52 week range with one buy rating fairly respectful from Wall Street at 4.2. Now firstly, let's talk about the earnings argument which is respectable unless they forecast $13.17 then 1439 then by 28570. That's roughly 9% growth we can see in each of the next few years. So I can see why someone would want to own the railroad. Now shareholders they are in fact paying a premium we can see forward P coming in 21 1.5 average sitting at 20. I want the cash flow to support this difference where the yield is also lower 1.9% against today's 2.3 for which the blue tunnel not an overvaluation signal just yet but sitting right at the upper end of a reasonable signal over the last 10 years. This one's traded for most of it at least in a reasonable signal. If you look 2020 to 2022, it did trade at premium. Very rare as well to see this anywhere near a severely undervalued region. Now, if we take a look at the DCF, bear in mind here that the most recent year free cash flow was down 7%, 5ear KGA neg3, 10 year KGA 3. We've used a 6% growth rate moving forwards. That's a massive disconnect between what spaked in today at 13.2, which is why we see a massive difference from today's price of 300 and the DCF value of 153. When we take a look at the other models, multiple that sits higher, 319. TDM, that sits higher than the DCF, but still lower than the price of 300. On average, we get 237 27% premium. Wall Street disagreement. They see 10% upside. Now, earnings. Whilst the growth is impressive for the company, I need a good reason to expect cash flow to keep outpacing earnings like that for a decade. As we saw with the reverse ETF, that's a bigger bet than this table suggests. UNP it goes into the sell category. We've got one slot left to decide. Remember that industrial stock deep in the red at the start. Here's why I take a closer look at this one. Caterpillars trading $559. The 52- week low, that's $537. 52- week high, sitting above $1,000. Year-to- date pretty much flat down only 2%. Your entry price here is very, very important. Now, even after the fall, the yield 1.2% 2% against a 5year of 1.7 forward multiple still above average 18.5 year at 16.8. So what exactly makes this my strongest buy? Well, the next two years of earnings they're the first piece from $27 to $32 to $389 around $19% growth we can see actually twice in 2027 and 2028. The estimates still have 27 analysts and 17 in the third one here at $559, you're paying under 21 times the first estimate. If the $ 38.54 comes through, today's purchase price would be around 14 1/2 times those earnings. That's a reasonably short path to a more attractive multiple. Now, analysts, they are, however, expecting a massive jump from 2025's reported 9 12 billion to 12 by 2026. That's a 32% lift before I apply 11% of growth the following years, which is pretty much in line with both 5-year and the 10-year KGA. Now, these assumptions give me $694 on the cash flow. The other methods multiple $840 DDM 932. Even setting both of these higher values aside or the cash flow model alone that suggests around 24% upside, we can see our largest margin of safety today so far, 32%. Wall Street also see the largest upside again so far, 45 price target above $800. But let's also do a quick stress test. If we say they have a tougher year, remove that 12 1.5 billion to let's say 10 1.5 billion. Well, the valuation, if we leave everything else alone, it drops to $569 a share. Almost all the upside goes away. That's the figure I'd keep coming back to. And I'd stick to the first three earnings estimate when judging. Once you look beyond 2028, the coverage, it drops down to just two analysts. The $51 estimate at the bottom as well, we can see is much narrow opinion than it looks. So the blended figure 822 buying at 558, it gives a 32% discount. Getting from 558 to 822, it would be a 47% gain. And the reverse DCF, that's the last check here from that 12 billion starting point. and the market needs around 8% annual growth against the 11 that I've used. I've got some room for error provided the starting point holds up. So, Caterpillar, it takes the top spot in buy ahead of Visa. I can cut Caterpillar's first cash flow estimate by $2 billion and still get close to the price. That's the sort of test that I want a buy to survive. Now, let's look back at Walmart where we started. the best thing that happened to its customers. Getting better value for their money is exactly what I'm looking for as a shelder. At around $127, I don't think I'm getting it. My bottom four, we've got Walmart, Apple, J&J, and Coca-Cola. The sale row where we've got here Costco, Starbucks, FedEx, and Union Pacific. At a lower price, I'd happily look at any of them. Again, these rankings belong to these prices. Of the holds, Ultra is the one I'd understand keeping for income. That 5.82% yield pays you while you wait for earnings growth. ABV is the one in the row that I take another look at first. For fresh money, Visa is the narrower buy. My valuation at 443 against today's price, where you could wipe out that gap with a small move in either the share price or the growth assumptions. Caterpillar, well, that's my first choice. I'd use a 694 cash flow estimate when deciding what I pay. The 822 average is interesting, but I don't need the 932 dividend valuation for the idea to work. Now, let me know in the comments below which one have I got most wrong. Pick one stock you'd move at least two rows and tell me where you'd put it and what price you pay. And if you enjoy today's episode, smash the like button, hit the subscribe and bell button so you're aware of future releases. And don't forget to click on the pin comment where you can sign up and read our weekly articles covering severely undervalued stocks as well as a brief market update. More importantly though, have a great day. I'll see you all on the next one.
Comentários 0
Entre para participar da discussão.
EntrarAinda não há comentários. Seja o primeiro a compartilhar sua opinião!